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Abstract 
Pharmaceutical products manufactured today must meet high microbiological specifications that the 
microbial content if not sterile should not exceed a minimum limit. Antacid suspensions are basic 
pharmaceutical multi-dose products that are used to neutralize gastric acid. They are highly susceptible to 
microbial contamination due to the neutral pH. In this study we attempted to assess the microbial quality 
of commercially available antacid suspensions in Sudan. Twelve batches belonging to four different 
companies were collected from different community pharmacies in Khartoum state; each company 
represented by three different batches which were represented by three products to compute the mean of 
the bioburden. The guideline of USP has been followed in all procedures and identification of the 
objectionable microorganisms. The testing conditions were examined by means of negative control. The 
enumeration of total viable count was done using pour plate method. We found that nine out of twelve of 
the tested batches exceed the USP limit for total microbial content (102 CFU/ml), and five of which were 
found to be contaminated with objectionable microorganisms. This study is expected to benefit the 
manufacturers of these products to pay more attention for the microbial quality of their products. 
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1. Introduction 
Pharmaceutical products used in diagnosis, treatment and prevention of disease contain different 
kinds of compounds and ingredients most commonly in complex physicochemical states [1]. 
These products must be manufactured according to the code of good manufacturing practice in 
all aspects in order to ensure safety and quality [1-3]. The quality of pharmaceutical products is 
of great concern that it should not be tested at the end of the day but it should be built in the 
product [2, 4]. One of the most important features of pharmaceutical product quality is the level 
of its microbial content that is needed to be strictly controlled [4-6]. 
Pharmaceutical products manufactured today must meet high microbiological specifications that 
the microbial content if not sterile should not exceed a minimum limit [1, 2, 7]. All these strict 
requirements are needed because of that, the consequences of microbial contamination of 
pharmaceutical products are highly serious particularly if the contaminating microorganisms 
have had the opportunity to multiply to high levels [1]. 
The assessment of such microbial quality is based on qualitative and quantitative tests that are 
used to enumerate the content of microorganisms as well as detection of specified objectionable 
ones [7, 8]. 
Antacid suspensions are basic pharmaceutical products that are used to neutralize hydrochloric 
acid in gastric secretions [9-14] these products are multi-dose formulation in which the therapeutic 
agents are dispersed in an external phase in which they are not very soluble [5, 6, 15]. The antacid 
suspensions are more commonly preferred than tablets due to their rapid activity and ability to 
neutralize gastric acid [14]. The most common antacid preparations used contain mixture of 
aluminum hydroxide and magnesium Hydroxide [9-11, 14]. These elements when exist in the form 
of oral suspensions are highly susceptible for microbial contamination, not only because of the 
water content which is considered as important source of contamination but also due to the 
neutral pH which make it favorable environment for the growth of some microbes [4-6] moreover, 
it's pH affects the action of the preservative by changing in its ionization state that alter the 
proportion of the un-dissociated and dissociated form, which have different intrinsic 
antimicrobial activity and ultimately prevent the preservative from attaining an adequate 
protective concentrations [5, 6]. 
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In order for the manufacturers to be able to manufacture 
pharmaceutical products that comply with compendial 
microbiological standards, they should be aware about the 
sources that are known to contribute to contamination of 
pharmaceutical products which are mainly the atmosphere, 
water, contaminated raw materials, equipment and personnel [1, 
5, 6, 14, 16, 17]. 
Microorganisms that contaminate pharmaceutical products or 
raw materials may be considered either as a source of infection 
to human [1, 3-6, 12, 14, 17] or may lead to spoilage if the resultant 
products of degradation can be utilized by the contaminating 
microorganisms as a source for biosynthesis and energy 
production which is likely to cause physicochemical changes of 
product which may be organoleptic with the release of very 
unpleasant smelling and tasting [1, 5, 6, 12, 14, 18] and further attack 
many of the suspending agents used in pharmaceutical 
suspensions causing depolymerization which may lead to 
physical instability of suspensions and ultimately sedimentation 
[1]. 
Not all pharmaceutical products are equally susceptible to 
microbial spoilage. The overall rate of deterioration will depend 
on the chemical structure of the ingredient, type and quantity of 
microorganisms contaminating the product [1] presence and 
concentration of the antimicrobial agent [6] pH, and finally the 
presence of sweetening agent which in some instances 
constitute a ready substrate for microbial attack [17] unless if 
used in high concentrations where it inhibits microbial attack [2, 
4, 15]. 
 
2. Materials and methods 
2.1 Sample collection 
This study was conducted on a sample of antacid oral 
suspensions that are collected from different community 
pharmacies in Khartoum state in Sudan. Thirty six products 
belonging to four different pharmaceutical companies were 
collected; each company was represented by three batches 
which were represented by three products to compute the mean 
of bioburden. 
2.2 Sample preparation and enumeration of total microbial 
count 
Following the guidelines of USP and under aseptic condition 
and after vigorous shaking ten ML of each antacid suspension 
was added to ninety ML of sterile peptone water (Himedia Ltd, 
India) and by making two-fold serial dilutions, The total 
microbial count has been determined by using pour plate 
method, in which one ML of each dilution was mixed with 15-
20 ML of sterile molten nutrient agar (Himedia Ltd, India) and 
15-20 ML sterile molten Sabrouaud dextrose agar (Himedia 
Ltd, India) for enumeration of bacteria and fungi respectively, 
and then poured in sterile disposable petri dish. The plates of 
nutrient agar were incubated at 30-35 0C for 5 days where as the 
plates of Sabrouaud dextrose agar was incubated at 25 0C for 7 
days.  
 
2.3 Detection of specified microorganisms 
For detection of objectionable microorganisms, from each 
antacids suspension ten ML was added to ninety ML of sterile 
peptone water, then 10 ML from this mixer was added to 90 Ml 
sterile soybean casein digest broth and incubated at 30-35 0C for 
18 to 24 hours, then 1 ML was taken from each sample and 
mixed with 16-20 ML of sterile molten mannitol salt agar 
(Himedia Ltd, India), cetramide agar (Himedia Ltd, India) and 
xylose lysein deoxycholate (Himedia Ltd, India) for detection 
of Staphylococcus aureus, Pseudomonas aeruginosa and 
Salmonella spp respectively, the plate were incubated at 30-35 
0C for 18-48 hours. For confirmatory tests of objectionable 
microorganisms, catalase (Bells, UK) and coagulase were done 
for Staphylococcus aureus, KIA (Himedia Ltd, India), urea 
fermentation (Himedia Ltd, India), citrate utilization (Himedia 
Ltd, India) and oxidase test (Himedia Ltd, India) were used to 
identify E. coli, Pseudomonas aeruginosa and Salmonella. 
Germ tube test were used to identify Candida albicans. 
 
3. Results and Discussion 
Total bacterial count and objectionable microorganisms isolated 
from products. 
 
Table 1: The table illustrate the total viable count for three batches (A-1, A-2 and A-3) from same company and each batches represented by 
three products and the mean of total viable count was calculated for each batches. 
 
Batch 
No 
Total viable 
count (cfu/ml) 
Pseudomonas 
aeruginosa 
Escherichia 
coli 
Salmonella 
spp 
Staphylococcus 
aureus 
Candida 
albicans 
A-1 1.5x103 - - - + - 
A-2 3.5x102 - - - + - 
A-3 5.01x104 - - - - - 
 
Table 2: The table illustrate the total viable count for three batches (B-1, B-2 and B-3) from same company and each batches represented by 
three products and the mean of total viable count was calculated for each batches. 
 
Batch 
No 
Total viable 
count (cfu/ml) 
Pseudomonas 
aeruginosa 
Escherichia 
coli 
Salmonella 
spp 
Staphylococcus 
aureus 
Candida 
albicans 
B-1 8.15x103 - - - + + 
B-2 2.33x102 - - - - + 
B-3 6x102 - - - - + 
 
Table 3: The table illustrate the total viable count for three batches (C-1, C-2 and C-3) from same company and each batches represented by 
three products and the mean of total viable count was calculated for each batches. 
 
Batch 
No 
Total viable 
count (cfu/ml) 
Pseudomonas 
aeruginosa 
Escherichia 
coli 
Salmonella 
spp 
Staphylococcus 
aureus 
Candida 
albicans 
C-1 2.16X101 - - - - - 
C-2 6X101 - - - - - 
C-3 1.6X104 - - - - - 
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Table 3 The table illustrate the total viable count for three batches (D-1, D-2 and D-3) from same company and each batches represented by 
three products and the mean of total viable count was calculated for each batches. 
 
Batch No 
Total viable 
count (cfu/ml) 
Pseudomonas 
aeruginosa 
Escherichia 
coli 
Salmonella 
spp 
Staphylococcus 
aureus 
Candida 
albicans 
D-1 0.5X101 - - - - - 
D-2 6X102 - - - - - 
D-3 2X106 - - - - - 
 
4. Discussion 
Antacid oral suspensions are highly susceptible to microbial 
contamination mainly due to its neutral pH. The present study 
was done in order to show if the commercially available antacid 
oral suspensions in Sudan comply with the compendial 
microbiological standards particularly the USP specifications. 
We found that nine out of twelve batches of the antacid 
suspensions tested were exceeded the USP limit for total 
microbial content (102 CFU/ml), and five of which were found 
to be contaminated with objectionable microorganisms namely 
Staphylococcus aureus and Candida albicans. 
In all mentioned previous studies on microbiological quality of 
antacid suspensions conducted in Bangladesh in (2004, 2012 
and 2014) and the other one conducted in Nigeria in 2012 
detected the presence of staphylococcus aureus with high load. 
Three batches out of twelve were found to be contaminated with 
staphylococcus aureus, two of them belonging to the same 
pharmaceutical company. It appears from these results that 
among the objectionable microorganisms staphylococcus 
aureus is the most common which indicate that either poor 
personal hygiene as the staphylococcus aureus is considered as 
part of the normal flora of human skin or production 
environment could also participate as a source of contamination 
with staphylococcus aureus. Presence of Candida albicans in 
three batches belonging to the same manufacturer is also 
indicative for inadequate personal hygiene, while the absence of 
Pseudomonas aeruginosa, E. coli and Salmonella spp. in our 
entire samples indicate lacking of fecal contamination.  
 
5. Conclusion 
With regard to this study and other similar studies made along 
the world about the microbiological quality of oral antacid 
suspensions, it appears that the manufacturers of these antacid 
suspensions really face problem with the microbial quality of 
these products which may be the cause behind the low number 
of these products in the market, this may be due to failure to 
implement efficiently all principles of GMP or failure to achieve 
effective preservation system. Further studies should be 
conducted to find out which type of preservatives would be 
effective against microorganisms native to manufacturer 
production environment. This study is expected to benefit the 
manufacturers of these products to pay more attention for the 
microbiological quality of their product, manufacturing 
environment and to give more training for the operating 
personnel about personal hygiene. 
 
5.1 Declaration of interest 
Authors declared that there is no conflict of interest in this 
study. 
 
6. References 
1. Hugo WB, Russell AD. Pharmaceutical microbiology. 
Blackwell science, 1998. 
2. Lachman L, Lieberman HA, Kanig JL. The theory and 
practice of industrial pharmacy. Lea & Febiger, 2013. 
3. Ratajczak M, Kubicka MM, Kamińska D, Sawicka P, 
Długaszewska J. Microbiological quality of non-sterile 
pharmaceutical products. Saudi Pharmaceutical Journal. 
2015; 31:23(3):303-7. 
4. Hugo WB, Russell AD. Pharmaceutical microbiology. 
Blackwell science, 2004. 
5. Aulton ME. Pharmaceutics. The science of dosage form 
design. Churchill livingstone, 2002. 
6. Aulton ME, Taylor KM. Aulton's pharmaceutics: the 
design and manufacture of medicines. Elsevier Health 
Sciences, 2013.  
7. Pharmacopeia US. USP 34-NF 29.General Chapter on 
Validation of Compendial Procedures. 2011, 1225. 
8. British Pharmacopoeia Commission, General Medical 
Council (Great Britain), Great Britain.Medicines 
Commission. British pharmacopoeia. Her Majesty's 
Stationery Office, 2001.  
9. Barar FS. Text Book of Pharmacology. Indian Journal of 
Pharmacology. 1994; 1:26(3)237.  
10. Martindale i. Martindal_e’s. 
11. Asperheim MK, Eisenhauer LA. The Pharmacologic Basic 
of Patient Care. Phil. London Toronto WB. 
Saunderscompany, 1981. 
12. Udeze AO, Jayeoba T, Innocent-Adiele HC, Okerentugba 
PO, Nwanze JC, Onoh CC, et al. Bacteriological 
Assessment of Some Selected Antacid Suspension 
Products In Nigeria. NY Sci J. 2012, 5. 
13. Ali RS, Amini M. Deterioration of parabens in preserved 
magnesium hydroxide oral suspensions. Journal of Applied 
Sciences. 2007; 7(21):3322-5. 
14. Khan JA, Khan IU, Iqbal Z, Nasir F, Muhammad S, 
Hannan PA, et al. Microbial spoilage, instability risk of 
antacid suspension in the presence of commonly used 
preservative system. Pakistan journal of pharmaceutical 
sciences. 2015; 1:28(5):1637-46. 
15. Jones D. FAST track Pharmaceutics-Dosage form and 
Design. Pharmaceutical Press, 2008. 
16. Urmi NJ, Noor RA. Microbiological profile and the anti-
bacterial traits of commonly available antacid suspensions 
in Dhaka metropolis. Int J Pharm Pharm Sci. 2014; 
6(4):174. 
17. Emejuru MC, Ojiegbe GC, Azi S, Nwosu NB. 
Microbiological Load of Selected Oral Liquid 
Pharmaceuticals. International Journal of Community 
Research. 2014; 8:2(3):39-45. 
18. Dafale NA, Semwal UP, Agarwal PK, Sharma P, Singh 
GN. Evaluation of preservative effectiveness in antacid, 
cough syrup and ophthalmic solution by microbial 
challenge test. 
 
View publication stats
See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/320268627
Microbiological quality assessment of antacid suspensions available in Sudan
Article · January 2016
CITATIONS
0
READS
295
5 authors, including:
Some of the authors of this publication are also working on these related projects:
estableshment of invitro culture of giardia sp from fecal sample of suspected patients View project
Anas Elnazeer
International University of Africa
6 PUBLICATIONS   1 CITATION   
SEE PROFILE
All content following this page was uploaded by Anas Elnazeer on 07 October 2017.
The user has requested enhancement of the downloaded file.
